The current world-wide economic recession has meant that the decision-making process for purchasing new instrumentation has gained more importance and priority for laboratory managers.
The process requires careful consideration of cost and, even more important, comparable data on the reliability and dependability of a particular instrument. At the present time it is often very difficult to obtain objective, comparable data. When a new item of equipment comes on the market a prospective purchaser often has little information about its performance, other than that from the manufacturer, or perhaps a colleague who might have done a trial for the manufacturer. Neither of these sources could be considered independent and it is unlikely that any testing will have followed a carefully designed and internationally accepted protocol. Therefore, many laboratories perform extensive evaluation studies before a purchase decision is made.
Standardization of evaluation studies would improve the comparability of the results reported Several (table 3) . It is to be hoped that these guidelines will soon be adopted by manufacturers and customers. [12] of atomic absorption spectrometers [13] of nephrelometers (in preparation) of blood-gas analysers (in preparation) of ion-selective electrodes (in preparation)
The principal goal of stage 2 is to verify the specifications which have been set up during stage (table 4) . During a 1978 workshop conference organized by the Commission of the European Communities under the title 'A plan for the use of national resources for evaluating instruments employed in clinical laboratory sciences', the idea ofa co-ordinated multicentre evaluation trial was proposed as a way of achieving comparability between the results from different laboratories.
Such multi-centre evaluations should last for no more than three to six months. Although special attention was paid to the statistical part of the document, several comments received show that it is difficult to find a proposal which suits all possible users. There seems to be general agreement that classical regression analysis should be abandoned in favour of either standardized principal component analysis [-5] or another non-parametric procedure [6] . In stage 1, performance claims can be obtained by following the NCCLS protocols especially designed for this purpose. It may also be possible to use parts of the multi-centre protocol to determine precision, accuracy, carry-over, etc., in either the manufacturer's own and/or external laboratories. The laboratories establishing and verifying the claims should not be identical, some overlap, however, may be acceptable. Data obtained from a multi-centre evaluation may later be used by the manufacturer when performance characteristics are published.
The third and last stage (. Therefore, the next step would be to co-ordinate several trials in one multi-centre evaluation. Major advantages of this concept are:
(1) Comparable data on the reliability of new instruments from several laboratories would be produced. Advantages (1), (2) and (3) improve the basis for decision-making on purchases; (4) and (5) 
